Orange Book product · Brand (NDA)
TRIOSTAT
LIOTHYRONINE SODIUM
At a glance
Dec 31, 1991
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 31, 1991
35 yr ago
Today
Pharmaceutical detail
Active ingredient
LIOTHYRONINE SODIUM
Strength
EQ 0.01MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 020105
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —CYTOMELBrand (NDA)
NDA 010379 · KING PHARMS
- 2024LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 218070 · BIOCON PHARMA
- 2021LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 214803 · ZYDUS LIFESCIENCES
- 2018LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 211510 · TEVA PHARMS USA
- 2016LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 091382 · SUN PHARM
- 2012LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 200295 · SIGMAPHARM LABS LLC
- 2009LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 090326 · PHARMOBEDIENT
- 2009LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 090097 · DR REDDYS LABS SA
- 2005LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 076923 · XGEN PHARMS
- 1982LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 085753 · WATSON LABS
- 1982LIOTHYRONINE SODIUMGeneric (ANDA)
ANDA 085755 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
